Fat distribution, HbA1c and hypoglycaemia in overweight and obese patients with type 2 diabetes: a comparison of NPH and insulin detemir from a pilot randomised clinical trial

被引：0
|
作者：
Tinahones, F. J. [1 ]
Gomez-Huelgas, R. [2 ]
Garcia-Alegria, J. [3 ]
Tapia-Guerrero, M.
Martos-Perez, F. [4 ]
机构：
[1] Hosp Virgen de la Victoria, Malaga, Spain
[2] Hosp Carlos Hayer, Dept Internal Med, Malaga, Spain
[3] Hosp Costa del Sol, Marbella, Spain
[4] Hosp Alta Resoluc, Benalmadena, Spain
来源：
DIABETOLOGIA | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
671
引用
收藏
页码：S273 / S273
页数：1
相关论文
共 50 条
  • [31] A COMPARISON OF INSULIN ADHERENCE IN PATIENTS WITH TYPE-2 DIABETES INITIATING THERAPY WITH INSULIN DETEMIR FLEXPEN® OR NPH INSULIN IN A VIAL
    Buysman, E.
    Conner, C.
    Liu, F.
    Aagren, M.
    Bouchard, J.
    VALUE IN HEALTH, 2011, 14 (03) : A98 - A98
  • [32] A Comparison of Insulin Adherence in Patients with Type 2 Diabetes Initiating Therapy with Insulin Detemir in a Pen Device or NPH Insulin in a Vial
    Buysman, Erin K.
    Conner, Christopher
    Liu, Fang
    Aagren, Mark
    Bouchard, Jonathan
    DIABETES, 2011, 60 : A628 - A628
  • [33] Insulin secretion and sensitivity as determinants of HbA1c in type 2 diabetes
    Monnier, L
    Colette, C
    Thuan, JF
    Lapinski, H
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 (04) : 231 - 235
  • [34] Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA1c without causing weight gain or increased hypoglycaemia
    Rosenstock, J.
    Rendell, M. S.
    Gross, J. L.
    Fleck, P. R.
    Wilson, C. A.
    Mekki, Q.
    DIABETES OBESITY & METABOLISM, 2009, 11 (12): : 1145 - 1152
  • [35] Effects of exercise training on HbA1c and VO2peak in patients with type 2 diabetes and coronary artery disease: A randomised clinical trial
    Byrkjeland, Rune
    Njerve, Ida U.
    Anderssen, Sigmund
    Arnesen, Harald
    Seljeflot, Ingebjorg
    Solheim, Svein
    DIABETES & VASCULAR DISEASE RESEARCH, 2015, 12 (05): : 325 - 333
  • [36] Long-term clinical outcomes of insulin detemir versus NPH for type 1 diabetes patients in Spain
    Kotchie, R.
    Aagren, M.
    Nielsen, S.
    Valentine, W. J.
    Goodall, G.
    VALUE IN HEALTH, 2007, 10 (06) : A273 - A273
  • [37] Depressive symptoms and HbA1c in patients with Type 1 and Type 2 diabetes
    Kawada, T.
    DIABETIC MEDICINE, 2014, 31 (06) : 759 - 760
  • [38] Efficacy and Safety of Empagliflozin (EMPA) in Younger, Overweight/Obese Patients with Type 2 Diabetes (T2DM) with HbA1c ≥8%
    Merker, Ludwig
    Lund, Soren S.
    Hantel, Stefan
    Salsali, Afshin
    Kim, Gabriel
    Broedl, Uli C.
    Woerle, Hans J.
    Hach, Thomas
    DIABETES, 2014, 63 : A280 - A281
  • [39] Treatment with insulin detemir once daily is associated with lower risk of hypoglycemia at similar levels of HbA1c compared to once-daily NPH insulin in subjects with type 1 diabetes mellitus
    Shaw, Jonathan E.
    Larsen, Jens
    Pedersen, Claus B.
    Tang-Fui, Serge
    DIABETES, 2008, 57 : A595 - A595
  • [40] Trajectories of HbA1c after initiation of insulin therapy in type 2 diabetes mellitus patients
    Mast, R.
    Walraven, I.
    Hoekstra, T.
    Jansen, D.
    van der Heijden, A. A. W.
    Elders, P. J. M.
    Heine, R. J.
    Dekker, J. M.
    Hugtenburg, J. G.
    Nijpels, G.
    DIABETOLOGIA, 2014, 57 : S385 - S385
12345